Effect of nitrogen-containing bisphosphonates on osteoclasts and osteoclastogenesis: an ultrastructural study
Abstract
We have previously indicated that a single injection of alendronate, one of the nitrogen-containing bisphosphonates (NBPs), affects murine hematopoietic processes, such as the shift of erythropoiesis from bone marrow (BM) to spleen, disappearance of BM-resident macrophages, the increase of granulopoiesis in BM and an increase in the number of osteoclasts. NBPs induce apoptosis and the formation of giant osteoclasts in vitro and/or in patients undergoing long-term NBP treatment. Therefore, the time-kinetic effect of NBPs on osteoclasts needs to be clarified. In this study, we examined the effect of alendronate on mouse osteoclasts and osteoclastogenesis. One day after the treatment, osteoclasts lost the clear zone and ruffled borders, and the cell size decreased. After 2 days, the cytoplasm of osteoclasts became electron dense and the nuclei became pyknotic. Some of the cells had fragmented nuclei. After 4 days, osteoclasts had euchromatic nuclei attached to the bone surface. Osteoclasts had no clear zones or ruffled borders. After 7 days, osteoclasts formed giant osteoclasts via the fusion of multinuclear and mononuclear osteoclasts. These results indicate that NBPs affect osteoclasts and osteoclastogenesis via two different mechanisms.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NBPs first induce osteoclast apoptosis and then formation of newly differentiated osteoclasts that can anchor the bone surface but cannot form a clear zone or ruffled border.
“A recent study with transmission electron microscopy demonstrated that NBPs first induce osteoclast apoptosis and then the formation of newly differentiated osteoclasts that can anchor the bone surface but cannot form a clear zone or ruffled border.157”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [157]
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997 · see citing works
(1990) · Elsevier eBooks · doi:10.1016/c2009-0-34738-8 · Cited by 1,073 · see citing works
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D., Mundy, G. R., & Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,039 · see citing works
Dunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H., & Rogers, M. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38786-5 · Cited by 901 · see citing works
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050645 · Cited by 890 · see citing works
Häcker, G. A. (2000) · Cell and Tissue Research · doi:10.1007/s004410000193 · Cited by 804 · see citing works
Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
McHugh, K. P., Hodivala-Dilke, K., Zheng, M., Namba, N., Lam, J. D., Novack, D., Feng, X., Ross, F., Hynes, R. O., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8905 · Cited by 786 · see citing works
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Roelofs, A. J., Thompson, K., Gordon, S., & Rogers, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0843 · Cited by 566 · see citing works
Biochemical and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Crockett, J. C., Coxon, F. P., & Mönkkönen, J. (2010) · Bone · doi:10.1016/j.bone.2010.11.008 · Cited by 532 · see citing works
Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
Weinstein, R. S., Roberson, P. K., & Manolagas, S. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802633 · Cited by 391 · see citing works
Mönkkönen, H., Auriola, S. O. K., Lehenkari, P. P., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706628 · Cited by 280 · see citing works
Integrin expression in human bone
Hughes, D. E., Salter, D. M., Dedhar, S., & Simpson, R. J. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080503 · Cited by 249 · see citing works
Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro
Benford, H. L., McGowan, N. W. A., Helfrich, M., NUTTALL, M. E., & Rogers, M. J. (2001) · Bone · doi:10.1016/s8756-3282(01)00412-4 · Cited by 235 · see citing works
Role of αvβ3 integrin in osteoclast migration and formation of the sealing zone
Nakamura, I., Pilkington, M. F., Lakkakorpi, P. T., Lipfert, L., Sims, S. M., Dixon, S. J., Rodan, G. A., & Duong, L. T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.22.3985 · Cited by 198 · see citing works
Faccio, R., Novack, D. V., Zallone, A. Z., Ross, F. P., & Teitelbaum, S. L. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212082 · Cited by 178 · see citing works
In VivoEffects of Bisphosphonates on the Osteoclast Mevalonate Pathway
Fisher, J., Rodan, G. A., & Reszka, A. A. (2000) · Endocrinology · doi:10.1210/endo.141.12.7921 · Cited by 150 · see citing works
Jobke, B., Milovanovic, P., Amling, M., & Busse, B. (2014) · Bone · doi:10.1016/j.bone.2013.10.024 · Cited by 123 · see citing works
Guy, J. A., Shea, M., Peter, C. P., et al. (1993) · Calcified Tissue International · doi:10.1007/bf01320915 · Cited by 97 · see citing works
Endo, Y., Nakamura, M., Kikuchi, T., et al. (1993) · Calcified Tissue International · doi:10.1007/bf00298728 · Cited by 94 · see citing works
Self-citationα9β1: A Novel Osteoclast Integrin That Regulates Osteoclast Formation and Function
Rao, H., Lu, G., Kajiya, H., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060718 · Cited by 86 · see citing works
Blumsohn, A., Naylor, K. E., Assiri, A. M., et al. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.11.1592 · Cited by 77 · see citing works
Integrin‐associated molecules and signalling cross talking in osteoclast cytoskeleton regulation
Kong, L., Wang, B., Yang, X., He, B., Hao, D., & Yan, L. W. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15052 · Cited by 73 · see citing works
Neuroendocrine (Merkel Cell) Carcinomas of the Skin: An Ultrastructural Study of Nine Cases
Silva, E., & Mackay, B. (1981) · Ultrastructural Pathology · doi:10.3109/01913128109031497 · Cited by 69 · see citing works
Gong, L., Altman, R. B., & Klein, T. E. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328335729c · Cited by 67 · see citing works
c-Src Links a RANK/αvβ3 Integrin Complex to the Osteoclast Cytoskeleton
Izawa, T., Zou, W., Chappel, J., Ashley, J. W., Feng, X., & Teitelbaum, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00077-12 · Cited by 65 · see citing works
Endo, Y., Kumamoto, H., Nakamura, M., Sugawara, S., Takano‐Yamamoto, T., Sasaki, K., & Takahashi, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-01020 · Cited by 61 · see citing works
Self-citationGroß, C., Weber, M., Creutzburg, K., Möbius, P., Preidl, R. H. M., Amann, K., & Wehrhan, F. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1230-8 · Cited by 59 · see citing works
Positive and negative regulators of osteoclast apoptosis
Soysa, N. S., & Alles, N. (2019) · Bone Reports · doi:10.1016/j.bonr.2019.100225 · Cited by 49 · see citing works
Endo, Y., Shibazaki, M., Yamaguchi, K., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702367 · Cited by 45 · see citing works
Self-citationEffects of bisphosphonates on osteoclastogenesis in RAW264.7 cells
Yoshimura, Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.952 · Cited by 38 · see citing works
Ultrastructural traits of apoptosis
Snigirevskaya, E. S., & Komissarchik, Y. Y. (2019) · Cell Biology International · doi:10.1002/cbin.11148 · Cited by 34 · see citing works
A time kinetic study of the effect of aminobisphosphonate on murine haemopoiesis
Nakamura, M., Yagi, H., Endo, Y., Kosugi, H., Ishi, T., & Itoh, T. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01774.x · Cited by 32 · see citing works
Self-citationTreatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate)
O'Rourke, N., McCloskey, E., Rosini, S., Coleman, R., & Kanis, J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.176 · Cited by 30 · see citing works
Giant osteoclasts in patients under bisphosphonates
Mac‐Way, F., Trombetti, A., Noël, C., et al. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-31 · Cited by 18 · see citing works
Takito, J., & Nakamura, M. (2012) · Communicative & Integrative Biology · doi:10.4161/cib.20980 · Cited by 17 · see citing works
Self-citationLiu, H., Cui, J., Sun, J., Du, J., Feng, W., Sun, B., Li, J., Han, X., Liu, B., Yimin, et al. (2015) · Journal of Molecular Histology · doi:10.1007/s10735-015-9620-9 · Cited by 11 · see citing works
Taylor, H. C., Santa-Cruz, D. C., Teitelbaum, S. L., et al. (1988) · Bone · doi:10.1016/8756-3282(88)90025-7 · Cited by 9 · see citing works
The effect of alendronate on the expression of important cell factors in osteoclasts
Zhang, Q., Liu, M., Zhou, Y., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1630 · Cited by 8 · see citing works
Ru, Y., Zhao, S., Dong, S., Liang, H., & Wang, Y. (2017) · Ultrastructural Pathology · doi:10.1080/01913123.2017.1373176 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works
- Authors
- Takagi, Y., Inoue, S., Fujikawa, K., Matsuki-Fukushima, M., Mayahara, M., Matsuyama, K., Endo, Y., & Nakamura, M.
- Affiliations
- SHOWA Medical University (JP)
- Tohoku University (JP)
- Corresponding author
- Nakamura, Masanori
- Venue
- Microscopy
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-04
- Volume
- 70
- Issue
- 3
- Pages
- 302-307
- ISSN
- 2050-5698 (ISSN-L)
- 2050-5701
- OpenAlex
- W3107856623
- Cited by
- 10
- References
- 39
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 1
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Microscopy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology of Japan (24592777, 15K11022 and 20K18516)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- nitrogen-containing bisphosphonates, alendronate, osteoclasts, osteoclastogenesis, osteoclast ultrastructure, ruffled border, clear zone, osteoclast apoptosis, osteoclast fusion, bone resorption, bone marrow-derived macrophages
- MeSH terms
- Animals, Bone and Bones, Diphosphonates, Erythropoiesis, Male, Mice, Inbred BALB C, Nitrogen, Osteoclasts, Osteogenesis, Apoptosis, Alendronate, Microscopy, Electron, Transmission, Bone Density Conservation Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review